Lipid modification in people with diabetes

Author:

Morris David1

Affiliation:

1. Dr David Morris is a retired GP and Specialist Doctor in Diabetes, Clinical Undergraduate Tutor at Keele University and a Clinical Senior Lecturer at Aston University

Abstract

Dyslipidaemia is an important risk factor in the development of atherosclerotic cardiovascular disease in people with diabetes. This article discusses the lipid modifying therapies available, and the current evidence and guidance on their use in diabetes.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology (nursing)

Reference45 articles.

1. The new NICE lipid modification guidelines and their implications for diabetes care;Kirby M.;Diabetes Primary Care,2014

2. Cardiovascular outcomes trials with statins in diabetes

3. Association of LDL cholesterol, non‐HDL cholesterol and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta‐analysis;Boekholt SM;JAMA,2012

4. Summary of national guidance for lipid management for primary and secondary prevention of cardiovascular disease;Accelerated Access Collaborative NHS;Updated December,2022

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3